Micron Biomedical extended its Series A to $33M+ to accelerate commercialization of needle-free therapeutics and vaccines.
Micron Biomedical is a clinical-stage life science company committed to expanding access to vaccines and therapeutics globally through a proprietary dissolvable microarray technology for needle-free delivery
Micron Biomedical is a clinical-stage life science company committed to expanding access to vaccines and therapeutics globally through a proprietary dissolvable microarray technology for needle-free delivery.